Teleflex Inc (TFX)
191.71
+1.07
(+0.56%)
USD |
NYSE |
Nov 22, 16:00
191.81
+0.10
(+0.05%)
After-Hours: 20:00
Teleflex Free Cash Flow: 450.04M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | 450.04M |
| June 30, 2024 | 417.47M |
| March 31, 2024 | 429.52M |
| December 31, 2023 | 419.20M |
| September 30, 2023 | 379.68M |
| June 30, 2023 | 324.61M |
| March 31, 2023 | 276.28M |
| December 31, 2022 | 262.95M |
| September 30, 2022 | 373.24M |
| June 30, 2022 | 420.89M |
| March 31, 2022 | 537.43M |
| December 31, 2021 | 579.80M |
| September 30, 2021 | 564.98M |
| June 30, 2021 | 479.12M |
| March 31, 2021 | 468.32M |
| December 31, 2020 | 345.71M |
| September 30, 2020 | 307.39M |
| June 30, 2020 | 327.49M |
| March 31, 2020 | 265.21M |
| December 31, 2019 | 336.83M |
| September 30, 2019 | 318.11M |
| June 30, 2019 | 317.44M |
| March 31, 2019 | 325.97M |
| December 31, 2018 | 356.58M |
| September 30, 2018 | 330.88M |
| Date | Value |
|---|---|
| June 30, 2018 | 332.20M |
| March 31, 2018 | 342.10M |
| December 31, 2017 | 348.98M |
| September 30, 2017 | 355.70M |
| June 30, 2017 | 354.47M |
| March 31, 2017 | 374.24M |
| December 31, 2016 | 355.34M |
| September 30, 2016 | 374.36M |
| June 30, 2016 | 323.23M |
| March 31, 2016 | 271.46M |
| December 31, 2015 | 239.36M |
| September 30, 2015 | 189.60M |
| June 30, 2015 | 208.12M |
| March 31, 2015 | 217.14M |
| December 31, 2014 | 218.99M |
| September 30, 2014 | 243.96M |
| June 30, 2014 | 234.26M |
| March 31, 2014 | 204.03M |
| December 31, 2013 | 164.39M |
| September 30, 2013 | 113.93M |
| June 30, 2013 | 87.18M |
| March 31, 2013 | 99.62M |
| December 31, 2012 | 121.42M |
| September 30, 2012 | 75.00M |
| June 30, 2012 | 66.26M |
Free Cash Flow Range, Past 5 Years
262.95M
Minimum
Dec 2022
579.80M
Maximum
Dec 2021
398.31M
Average
398.57M
Median
Free Cash Flow Benchmarks
| Boston Scientific Corp | 1.892B |
| Becton Dickinson & Co | 3.073B |
| Globus Medical Inc | 293.77M |
| Glaukos Corp | -81.27M |
| PROCEPT BioRobotics Corp | -103.56M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 230.98M |
| Cash from Investing (Quarterly) | -21.23M |
| Cash from Financing (Quarterly) | -174.82M |
| Free Cash Flow Per Share (Quarterly) | 4.463 |
| Free Cash Flow to Equity (Quarterly) | 169.35M |
| Free Cash Flow to Firm (Quarterly) | 225.73M |
| Free Cash Flow Yield | 4.97% |